Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Senate Votes Down Effort to Expedite Ban on Human Cloning
Feb 11 1998
WASHINGTON, D.C. (February 11, 1998) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement after...
BIO Responds to Cloning Report
Jan 7 1998
(WASHINGTON, D.C., January 7, 1998)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
BIO Looks Forward to Implementation of FDA Reforms
Nov 21 1997
WASHINGTON, D.C. (November 21, 1997) _ Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today issued the following statement...
BIO Calls on President Clinton to Sign FDA Reform Bill Into Law
Nov 10 1997
(WASHINGTON, DC, November 10, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement in...
BIO lauds House of Representatives for "Moving FDA in New Direction" with passage of H.R. 1411
Nov 7 1997
(WASHINGTON, DC, October 7, 1997)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement on the House...
BIO's Statement on Cloned Lamb
Jul 24 1997
(WASHINGTON, DC)...Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement in response to the...
BIO's Response to Sheep Cloning Earns Virginia Public Relations Award
Jul 22 1997
(WASHINGTON, DC)...The Biotechnology Industry Organization (BIO) has been honored by the Public Relations Society of America (PRSA)/Richmond, VA chapter, for...
Binder Elected New BIO Chairman
Jun 19 1997
WASHINGTON, D.C., --- Gordon Binder, Chairman and CEO of Amgen Inc. has been elected Chairman of the Board for the Biotechnology Industry Organization (BIO...
BIO Supports Ban on Cloning of Humans, Seeks Medical Research Protection
Jun 7 1997
WASHINGTON, D.C.----Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement today in response to the...
International Biotechnology Community Supports Genetic Privacy - BIO Seeks White House Support
Jun 5 1997
WASHINGTON, D.C.-----Eleven international biotechnology organizations have endorsed the Biotechnology Industry Organization's (BIO) policy statement...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...